Patients With Schizophrenia Spectrum Disorder Are Less Likely to Receive Stage-Appropriate Treatment for Non-Small Cell Lung Cancer in Japan
Highlights
In a nationwide multicenter cohort of 166,663 patients treated for non-small cell lung cancer (NSCLC) in Japan, 1,346 had pre-existing schizophrenia spectrum disorder (SSD).
Patients with SSD were more often diagnosed with stage IV disease than patients without psychiatric disorders (45.0% vs 31.4%).
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.